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Abstract
Background: Several factors are known to interfere with electrocardiogram (ECG) sensitivity when diagnosing Left 
Ventricular Hypertrophy (LVH), with gender and cardiac mass being two of the most important ones.
Objective: To evaluate the influence of gender on the sensitivity of some of the criteria used to detect LVH, according 
to the progression of ventricular hypertrophy degree.
Methods: According to gender and the degree of LVH at the echocardiogram, the patients were divided in three 
groups: mild, moderate and severe LVH. ECG sensitivity to detect LVH was assessed between men and women, 
according to the LVH degree. 
Results: Of the 874 patients, 265 were males (30.3%) and 609, females (69.7%). The [(S + R) X QRS], Sokolow-Lyon, 
Romhilt-Estes, Perugia and strain criteria showed high discriminatory power in the diagnosis of LVH between men 
and women in the three groups with LVH, with a superior performance in the male population and highlighting the 
importance of the [(S + R) X QRS] and Perugia scores.
Conclusion: The diagnostic sensitivity of the ECG increases with the cardiac mass, The examination is more 
sensitive in men. highlighting the importance of the [(S + R) X QRS] and Perugia scores. (Arq Bras Cardiol 2011; 
97(3) : 225-231)
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Introduction
Left Ventricular Hypertrophy (LVH) is an independent 
predictor of morbimortality in the general population when 
diagnosed by either the ECG or the echocardiogram1,2.
Since the pioneer observations of the Framingham Heart 
Study, several epidemiological studies have highlighted LVH 
as one of the most important risk factors for angina pectoris, 
myocardial infarction, heart failure, cerebrovascular accident 
and sudden death3.
Among the several propaedeutic methods for the diagnosis 
of LVH, the least expensive, most broadly disseminated and 
easier to interpret method is the electrocardiogram (ECG), 
which presents high specificity, although it has low diagnosis 
sensitivity. However, in spite of this limitation, it remains 
a broadly used complementary test in medical practice as 
well as in population studies, in the prevention as well as 
in the analysis of regression of the hypertrophic process3,4. 
Additionally, the ECG has excellent reproducibility, being very 
useful in the clinical follow-up of the patients. 
Some situations can alter the ECG sensitivity in the LVH 
diagnosis, with gender being one of the most important5-7.
The objective of the present study was to assess the 
influence of gender on the sensitivity of some criteria used for 
LVH detection, according to the progression of the ventricular 
hypertrophy degree. 
Methods
From March 2006 to December 2009, 12-lead 
electrocardiograms of 874 hypertensive patients that were 
followed at the outpatient clinic and regularly used anti-
hypertensive medication were analyzed. Patients that had 
orovalvular disease, acute or chronic coronary artery disease, 
previous myocardial infarction, Chagas’ disease, rhythm 
disorders, bundle branch blocks, used digitalis, had ventricular 
pre-excitation syndrome, patients with large left ventricular 
(LV) masses and those with inadequate technical quality of the 
echocardiogram or any other condition that could potentially 
distort the LV geometry and the electrocardiographic analysis, 
were excluded. 
The study protocol was approved by the Ethics Committee 
in Research of Universidade Federal de São Paulo - Escola 
Paulista de Medicina (Unifesp-EPM).
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Electrocardiogram
The resting ECG was carried out with the patient in the 
supine position, obtaining the 12-lead electrocardiogram with 
a velocity of 25 mm/s, standard calibration for 1.0 mV/cm 
(Dixtal EP3 equipment, Brazil). The ECG tracing was decoded 
and, for the analysis of several variables, a magnifying lens that 
allowed a magnification of 5x on its contact surface with the 
tracing was used, to obtain higher precision in the analysis. 
The QRS complex axis and duration, the R-wave amplitude 
in leads D1, aVL, V5 and V6, the S-wave amplitude in V1, V2 
and V3, the strain pattern in V5 and V6, as well as a higher 
amplitude of the R and S waves in the horizontal plane leads 
were quantified by the same observer, a very experienced 
cardiologist. Eight LVH electrocardiographic criteria were 
separately analyzed. 
1. Higher S + higher R in the horizontal plane multiplied 
by the longest duration of QRS [(S + R) X QRS]: addition of 
higher amplitude of S wave with the higher amplitude of R 
wave in the horizontal plane (em mm), multiplying the total 
by the duration of the QRS complex (in seconds), where the 
latter is the broadest, normally in leads V2 or V3. The LVH 
score by the ECG is defined when the result is ≥ 2.8 mm.s8.
2. Sokolow-Lyon voltage criterion: SV1 + RV5 or V6 ≥ 35 mm
9. 
3. Cornell voltage criterion: RaVL + SV3 ≥ 20 mm for women 
and ≥ 28 mm for men10.
4. Cornell duration criterion: (RaVL + SV3) X QRS duration; 
for women, add 8 mm, ≥ 2440 mm.ms11.
5. Romhilt-Estes score: higher amplitude of R or S ≥ 30 mm 
in the horizontal plane or ≥ 20 mm in the frontal plane or strain 
pattern in V5 or V6 (when using digital it is worth only one point) 
or left atrial enlargement by the Morris index (three points); 
ÂQRS electrical axis > -30 degrees (two points); QRS duration 
≥ 90 ms in V5 or V6 or ventricular activation time ≥ 50 ms in V5 
or V6 (one point). Using this score, LVH is diagnosed when the 
score ≥ 5 points12.
6. R wave of aVL ≥ 11 mm
13.
7. Perugia score: LVH is diagnosed by the presence of one or 
more of the following findings: Cornell criteria, considering the 
limit for women ≥ 20 mm and for men ≥ 24 mm, Romhilt-Estes 
score and strain pattern14.
8. Presence of strain pattern: defined as a convex depression 
of ST segment with asymmetric inversion of T wave opposed to 
the QRS complex in leads V5 or V6
5.
The analysis of method reproducibility was carried out by 
three observers that independently interpreted 100 ECG tracings 
randomly removed for analysis of the amplitude of the R and S 
waves and QRS complex duration.
 
Transthoracic Echocardiogram 
The examinations were carried out at the Doppler 
Echocardiography Service of Unifesp-EPM (ATL 1500 
equipment, USA), with de 2.0 and 3.5 MHz transducers. 
The patient was positioned in left lateral decubitus and 
the images were obtained from the left parasternal region 
between the fourth or fifth intercostal space and the usual 
slices were performed to carry out the complete study in 
M-mode and two-dimensional mode, simultaneously to the 
ECG registry. According to the recommendations of the Penn 
Convention, the following measurements were obtained: LV 
size in systole and diastole; thickness of the interventricular 
septum and LV posterior wall at the end of the diastole, left 
ventricular-end diastolic and systolic volume, percentage 
of diastolic shortening and ejection fraction by the cube 
method. LV mass was calculated by the formula:  LV mass 
= 0.8 X {1.04 [(IVSD + LVEDD + LVPWD)3 – (LVEDD)3]} 
+ 0,6 g15, where IVSD is the interventricular septum in 
diastole, LVEDD is the left ventricular end-diastolic diameter 
and LVPWD is the LV posterior wall in diastole. The LV mass 
was indexed for body surface area to adjust for differences 
in heart size according to the patient’s size. Body surface 
was calculated by the formula: BS = (W – 60) X 0.01 + 
H, where BS is the body surface in m2, W is the weight in 
Kg and H is height in meters16. Body Mass Index (BMI) was 
calculated by dividing the weight (Kg) by the square height 
(m). The patients were divided by gender and degree of 
ventricular hypertrophy, calculated by the echocardiogram, 
according to the recommendations of the American 
Society of Echocardiography/European Association of 
Echocardiography17, as summarized in Table 1. Thus, mild 
LVH was considered, for the female population, when the 
LVMI was 89-100 g/m2; moderate LVH with LVMI of 101-
112 g/m2 and severe LVH with LVMI > 113 g/m2. For the 
male population, these values were 103-116 g/m2; 117-130 
g/m2 and > 131 g/m2, respectively. The study of diagnostic 
sensitivity was carried out in the eight ECG methods 
evaluated herein, with the three degrees of hypertrophy 
described, always comparing the results obtained between 
men and women. 
Statistical Analysis 
Continuous variables were expressed as means and 
standard deviations. Categorical variables were expressed 
as percentages. All significance probabilities (p values) are 
two-tailed. Sensitivity values were estimated in each one of 
two independent samples and then compared using Fisher 
Exact Test.  Kappa test was used for the reproducibility 
study18. In this test, values > 0.75 are considered excellent 
ones; values < 0.40 are considered as poor concordance 
and those between 0.40 and 0.75 as good concordance. 
Statistical significance was verified in all comparisons by 
using 95% confidence intervals and a p value < 0.05. 
Results
Of the 874 patients included in the study, all with LVH 
identified by echocardiography, 265 were males (30.3%) 
and 609 were females (69.7%), with a mean age of 59.7 ± 
10.8 years. Table 1 shows the distribution by gender and 
by LVH degree, as well as the general characteristics of the 
studied sample. 
Regarding the sensitivity values, it can be observed that 
for almost all of them, the electrocardiographic criteria are 
more effective in diagnosing LVH in the male population, 
except for the Cornell voltage criteria, which was the only 
one with a better performance among female individuals in 
the three degrees of LVH, although statistically significant 
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only in the group with severe LVH. Only the [(S + R) X QRS] 
and Cornell voltage  criteria showed progressive sensitivity 
percentages according to the increase in LVH degree. In 
the studied population, the [(S + R) X QRS], Sokolow-Lyon, 
Romhilt-Estes, Perugia and strain pattern criteria showed high 
discriminatory power in the diagnosis of LVH between men 
and women in the three degrees of hypertrophy, with a much 
superior performance in the male population and highlighting 
the [(S + R) X QRS] and Perugia scores, as shown in Table 2.
As for the reproducibility study, the level of concordance 
among the three observers varied from 0.82 to 0.98, and 
were considered excellent. The first value corresponds to the 
QRS complex and the last to the amplitude of R and S waves. 
Figure 1 illustrates an ECG tracing of a patient from the 
present sample, which has all other electrocardiographic 
criteria of LVH studied herein, except for the criterion R of 
aVL ≥ 11 mm. Figure 2 shows the M-mode echocardiogram 
of the same patient, disclosing the three variables used for the 
calculation of LV mass. The interval between the examinations 
was 25 days. 
Discussion
The influence of gender and LV mass increase on the 
diagnostic sensitivity of the ECG in relation to LVH is clear. 
LVH is a marker of high cardiovascular risk, regardless of 
comorbidities, with no difference regarding ethnicity, presence or 
absence of systemic arterial hypertension or coronary disease, in 
both clinical and epidemiological studies, with a close association 
between LVH and adverse cardiovascular events. Hence, the 
importance of its detection by low-cost and easy-to-apply 
diagnostic methods in large populations, as well as the knowledge 
of interference in specific populations, as in the case of the male 
and female genders, the obese, the elderly and smokers6,19-21.
The LVH usually leads to an increase in the QRS complex 
amplitude, and, consequently, the electrical forces shift to the left 
and posteriorly, originating deep S waves in the right precordial 
leads. On the other hand, the higher transverse ventricular 
activation, a result of the LVH, causes an increase in QRS duration 
and intrinsicoid deflection (the interval from the earliest onset 
to the peak of the QRS complex in the left precordial leads)3,5.       
The present study used the transthoracic echocardiogram as 
a reference for the diagnosis of LVH. The modified Devereux 
formula15 has good correlation with the left ventricular mass in 
necropsy studies (r = 0.90; p < 0.001) and applies to normal 
geometry ventricles, considered to be ellipsoid and within 
standards that allow volume extrapolation by the cube formula. 
In spite of the undeniable contribution of the echocardiogram 
in the diagnosis and knowledge of LVH, its cost is much higher 
than that of the ECG, in addition to its methodological limitations 
regarding reproducibility, as it depends greatly on the observer, a 
fact that limits its use in epidemiological studies8.
As mentioned before, it is known that the electrocardiographic 
diagnosis of LVH is influenced by some factors, such as age, 
obesity, tobacco smoking and gender6, with the latter being of the 
object of the present study. Levy et al6 demonstrated, in patients 
from the Framingham Heart Study, that the prevalence of LVH 
was higher in women than in men at the echocardiographic study, 
a finding that was not confirmed at the ECG (women = 5.6%; 
men = 9.0%; p = 0.075).
Regarding the present sample, the patients were divided 
by gender and by progressive degrees of LVH. It is common 
knowledge that the ECG is an examination with high specificity 
and low sensitivity in the detection of LV in the general population 
of individuals with hypertrophic hearts. However, the accuracy 
behavior of this method with crescent degrees of left ventricular 
mass remains unknown, a fact that is very important considering 
that the myocardial cell hypertrophy increases the muscle mass 
globally, although that does not necessarily mean a higher 
electrical potential generation. In fact, this contradiction between 
a hypertrophied LV and the absence of QRS complex increment 
can be justified by a higher amount of collagen fibers in the heart. 
These fibers develop in parallel to the LVH process. As a result, 
there is an isolation of cardiac fibers, with consequent ischemia, 
cell death and substitutive repair by more collagen tissue. Hence, 
although the heart shows an increased mass, its capacity to 
generate electrical potential can be even decreased22-24. It is 
noteworthy the fact that the variables age, body surface and body 
mass index were very similar in both genders, which practically 
excludes the interference of these factors on LVMI. 
Okin et al25, in a study with 389 patients, of which 116 had 
LVH, suggested that the worse performance of the ECG in women 
might be partially attributed to the lower voltage and duration of 
QRS complexes, due to the differences in body surface and heart 
dimensions observed between the genders. On the other hand, 
Table 1 – Characteristics of the studied population by gender and LVH degree
Mild LVH (n=321) Moderate LVH  (n=216) Severe LVH  (n=337)
Variable M F M F M F
Gender (n) 89 232 60 156 116 221
Age (years) 59.2 ± 11.4 58.6 ± 10.4 60.4 ± 10.6 60.6 ± 9.5 61.1 ± 11.0 59.9 ± 11.6
BS (m2) 1.8 ± 0.1 1.6 ± 0.1 1.8 ± 0.1 1.6 ± 0.1 1.7 ± 0.1 1.6 ± 0.1
BMI 27.2 ± 6.3 28.4 ± 5.3 26.2 ± 3.8 28.3 ± 5.3 25.6 ± 3.4 28.0 ± 5.2
LVMI (g/m2) 109.3* 93.7* 123.9* 106.4* 153.4* 128.5*
*Median; LVH - left ventricular hypertrophy; M - male; F - female; BS - body surface; BMI - body mass index; LVMI - left ventricular mass index.
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Figure 1 – ECG of 51-year-old female patient with stage-3 arterial hypertension. Except for R of aVL ≥ 11 criterion, all other assessed criteria are present.
Figure 2 – M-mode echocardiogram of the same patient. The three variables used to calculate the left ventricular mass are shown: IVS = 20.4 mm; LVPW = 18.6 
mm and LVDd = 61.8 mm; (LVMI = 385.5 g/m2).
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it is known that the left ventricular mass indexation practically 
eliminates this problem15. 
At the study of diagnostic sensitivity of the ECG, the 
objective of the present study, one can observe an excellent 
performance of the [(S + R) X QRS], Sokolow-Lyon voltage, 
Romhilt-Estes, Perugia and strain pattern criteria, mainly 
with the progression of the hypertrophy degree, confirming 
that the ECG is more effective in diagnosing LVH in the male 
population, perhaps a reflection of the higher QRS complex 
expression (amplitude and duration) in male individuals24. In 
opposition to this logic, the exception was the Cornell voltage 
criteria, which, regarding the three degrees of LVH, had its 
best performance in females, although showing statistical 
significance only in the group with severe LVH. 
Alfakih et al7, in a study that evaluated three of the methods 
assessed here, having magnetic nuclear resonance as the 
reference standard for comparison of LVH, demonstrated that 
the Cornell voltage and duration criteria were more effective 
in diagnosing LVH in male individuals,  whereas the Sokolow-
Lyon product criterion was superior in the female population. 
Costa et al26, studying patients with chronic kidney disease 
stage 5, whose prevalence of LVH was 83% and mean LVMI 
of 154.9 ± 57.3 g/m2, also showed that the Sokolow-Lyon 
voltage, Sokolow-Lyon product, Cornell voltage, Cornell 
product and Romhilt-Estes criteria diagnosed more LVH in 
the male population. 
In the present study, the evaluation of the [(S + R) X QRS] 
score, which, in the original study that presented this new score 
with 1,204 controlled hypertensive patients, found a sensibility 
of 35.2% and a specificity of 88.7% for the diagnosis of LVH 
also showed good sensitivity, especially in the male population. 
This criterion, which uses the sum of the highest R wave and 
the highest S wave in the horizontal plane, multiplied by a 
higher duration of the QRS complex, has a consistent basis 
from the physical point of view, as the relation of increased 
electrical activity in LVH is shown by a spatial vector that has 
amplitude and duration. The higher expression of the R and 
S waves and the QRS complex represented by this vector 
showed good correlation with left ventricular mass8. 
One can conclude, based on the present series, that the ECG 
show better performance in the diagnosis of LVH as the LV mass 
increases. One can also conclude that, for any degree of LVH, 
the ECG is, in general, more sensitive to attain the diagnosis in the 
male sex. In this same population, the [(S + R) X QRS] and Perugia 
scores presented better sensitivity in the sample studied herein. 
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